Fairview Health Services
Fairview Health Services was paid $7.71M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99285, emergency room visit (most serious) — 33% of everything it billed.
WYOMING, MN 55092
Next to other Registered Dietitian providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,205 | $503K | |
| 2019 | 17,500 | $1.56M | |
| 2020 | 8,231 | $741K | |
| 2021 | 10,882 | $859K | |
| 2022 | 18,450 | $1.40M | |
| 2023 | 17,607 | $1.52M | |
| 2024incomplete | 11,626 | $1.13M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 33% | 9,018 | 8,145 | $2.56M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 20% | 19,886 | 18,755 | $1.55M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 8,265 | 7,255 | $1.54M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 8,224 | 7,349 | $1.23M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 1,548 | 1,401 | $155K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.8% | 1,147 | 1,111 | $138K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 1,244 | 1,084 | $104K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.3% | 799 | 778 | $102K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,434 | 7,611 | $56K |
| 80053 | Comprehensive metabolic panel | <1% | 8,292 | 7,530 | $50K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,909 | 1,834 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,427 | 1,290 | $29K |
43 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 280 | $23K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 509 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,471 | $18K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 343 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 256 | $12K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 108 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 625 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,128 | $10K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 117 | $8K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 152 | $6K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 96 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 111 | $3K |
| 94060 | <1% | 12 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 93 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 41 | $2K |
| 83690 | <1% | 693 | $2K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 233 | $1K |
| 87081 | <1% | 1,103 | $1K | |
| 94726 | <1% | 12 | $1K | |
| 84484 | <1% | 184 | $822.75 | |
| 94729 | <1% | 24 | $779.80 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,699 | $752.88 |
| 81001 | <1% | 1,402 | $721.13 | |
| 71045 | Radiologic examination, chest; single view | <1% | 13 | $551.97 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 897 | $546.26 |
| J3490 | Unclassified drugs | <1% | 60 | $517.89 |
| J2704 | Injection, propofol, 10 mg | <1% | 490 | $373.19 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 682 | $246.19 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 34 | $132.71 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 229 | $115.90 |
| 86140 | <1% | 64 | $99.92 | |
| 84703 | <1% | 15 | $91.70 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 198 | $89.43 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 18 | $31.13 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 63 | $20.19 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 563 | $16.75 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 144 | $16.32 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 58 | $12.38 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17 | $3.05 |
| 87807 | 0% | 14 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 16 | $0.00 |
| 81025 | 0% | 29 | $0.00 | |
| 85610 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
| Fairview Clinics | Princeton, MN | $4.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.